BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 27158098)

  • 1. Evaluation of different models of access to misoprostol at the community level to improve maternal health outcomes in Ethiopia, Ghana, and Nigeria.
    Wells E; Coeytaux F; Azasi E; Danmusa S; Geressu T; McNally T; Potts J; Otive-Igbuzor E; Tibebu S
    Int J Gynaecol Obstet; 2016 Jun; 133(3):261-5. PubMed ID: 27158098
    [No Abstract]   [Full Text] [Related]  

  • 2. A regional comparison of distribution strategies and women's awareness, receipt, and use of misoprostol to prevent postpartum hemorrhage in rural Amhara and Oromiya regions of Ethiopia.
    Sibley LM; Spangler SA; Barry D; Tesfaye S; Desta BF; Gobezayehu AG
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S73-82. PubMed ID: 24588919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interpretation of national policy regarding community-based use of misoprostol for postpartum hemorrhage prevention in Ethiopia: a tale of two regions.
    Spangler SA; Gobezayehu AG; Hailemariam TG; Sibley LM
    J Midwifery Womens Health; 2014 Jan; 59 Suppl 1():S83-90. PubMed ID: 24588920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community-based distribution of misoprostol to prevent postpartum haemorrhage at home births: results from operations research in rural Ghana.
    Geller S; Carnahan L; Akosah E; Asare G; Agyemang R; Dickson R; Kapungu C; Owusu-Ansah L; Robinson N; Mensah-Homiah J
    BJOG; 2014 Feb; 121(3):319-25. PubMed ID: 24283350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community mobilization to reduce postpartum hemorrhage in home births in northern Nigeria.
    Prata N; Ejembi C; Fraser A; Shittu O; Minkler M
    Soc Sci Med; 2012 Apr; 74(8):1288-96. PubMed ID: 22377106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scaling Up Misoprostol to Prevent Postpartum Hemorrhage at Home Births in Mozambique: A Case Study Applying the ExpandNet/WHO Framework.
    Hobday K; Hulme J; Prata N; Wate PZ; Belton S; Homer C
    Glob Health Sci Pract; 2019 Mar; 7(1):66-86. PubMed ID: 30926738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recommendations for scale-up of community-based misoprostol distribution programs.
    Robinson N; Kapungu C; Carnahan L; Geller S
    Int J Gynaecol Obstet; 2014 Jun; 125(3):285-8. PubMed ID: 24680582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of postpartum hemorrhage: options for home births in rural Ethiopia.
    Prata N; Gessessew A; Abraha AK; Holston M; Potts M
    Afr J Reprod Health; 2009 Jun; 13(2):87-95. PubMed ID: 20690252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tackling the unacceptable: Nigeria approves misoprostol for postpartum haemorrhage.
    Jadesimi A; Okonofua FE
    J Fam Plann Reprod Health Care; 2006 Oct; 32(4):213-4. PubMed ID: 17032506
    [No Abstract]   [Full Text] [Related]  

  • 10. Knowledge, acceptability, and use of misoprostol for preventing postpartum hemorrhage following home births in rural Ethiopia.
    Gebre B; Taddese Z; Deribe K; Legesse T; Omar M; Biadgilign S
    Int J Gynaecol Obstet; 2016 Jul; 134(1):79-82. PubMed ID: 27090217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges and Successes of Distributing Birth Kits with Misoprostol to Reduce Maternal Mortality in Rural Tanzania.
    Webber GC; Chirangi BM; Magatti NJ
    Afr J Reprod Health; 2019 Sep; 23(3):68-78. PubMed ID: 31782633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Misoprostol for Prevention of Postpartum Hemorrhage at Home Birth in Afghanistan: Program Expansion Experience.
    Haver J; Ansari N; Zainullah P; Kim YM; Tappis H
    J Midwifery Womens Health; 2016; 61(2):196-202. PubMed ID: 26849472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Misoprostol for preventing and treating postpartum hemorrhage in the community: a closer look at the evidence.
    Oladapo OT
    Int J Gynaecol Obstet; 2012 Nov; 119(2):105-10. PubMed ID: 22968139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Avoidable maternal deaths: three ways to help now.
    Prata N; Graff M; Graves A; Potts M
    Glob Public Health; 2009; 4(6):575-87. PubMed ID: 19326279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postpartum hemorrhage prevention in Nepal: a program assessment.
    Rajbhandari SP; Aryal K; Sheldon WR; Ban B; Upreti SR; Regmi K; Aryal S; Winikoff B
    BMC Pregnancy Childbirth; 2017 Jun; 17(1):169. PubMed ID: 28583092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date.
    Smith JM; Gubin R; Holston MM; Fullerton J; Prata N
    BMC Pregnancy Childbirth; 2013 Feb; 13():44. PubMed ID: 23421792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home use of misoprostol to prevent PPH. Editor's Comment.
    Fortney JA
    Int J Gynaecol Obstet; 2010 Mar; 108(3):268. PubMed ID: 20053401
    [No Abstract]   [Full Text] [Related]  

  • 18. Introducing misoprostol for the management of postpartum hemorrhage in Zimbabwe: final report on operational research.
    Zvandasara P; Chipato T; Mawere E; Rivelt K; McNally T
    Cent Afr J Med; 2015; 61(9-12):76-83. PubMed ID: 29144067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary on 'Community-based distribution of misoprostol: is this the way forward?'.
    Mathai M
    BJOG; 2014 Feb; 121(3):325-6. PubMed ID: 24575434
    [No Abstract]   [Full Text] [Related]  

  • 20. Modeling maternal mortality in Bangladesh: the role of misoprostol in postpartum hemorrhage prevention.
    Prata N; Bell S; Quaiyum MA
    BMC Pregnancy Childbirth; 2014 Feb; 14():78. PubMed ID: 24555848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.